The University of North Texas Health Science Center at Fort Worth (UNTHSC) received a Project Grant award of $268,377 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund the development and validation of a novel device that utilizes high-frequency, low amplitude vibration (HFLAV) to enhance healing of Stage 2 diabetic foot ulcers (DFUs) and improve quality of life for patients. The project aims to: 1) enhance and validate the HFLAV driver device by incorporating thermography to measure blood flow and tissue heat depth, and ensure it meets ISO safety standards; and 2) conduct a small clinical trial to evaluate the safety and efficacy of the HFLAV device in treating diabetic ulcer patients. The research is expected to run from February 2025 to January 2027, and could potentially save up to $2,000 per month in outpatient healthcare costs for DFU patients if the HFLAV device can accelerate wound healing by 30% compared to standard of care.
Generated 3/18/25, 4:57 AM